Problems, controversies, and perspectives on the clinical use of interleukin-2

Curr Opin Oncol. 1990 Dec;2(6):1139-45. doi: 10.1097/00001622-199012000-00019.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / therapeutic use
  • Cell Survival / drug effects
  • Drug Synergism
  • Drug Therapy, Combination
  • Humans
  • Interferon Type I / therapeutic use
  • Interleukin-2 / adverse effects
  • Interleukin-2 / therapeutic use*
  • Leukocyte Count / drug effects
  • Mice
  • Neoplasms / drug therapy*
  • Tumor Necrosis Factor-alpha / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Interferon Type I
  • Interleukin-2
  • Tumor Necrosis Factor-alpha